Skip to content

    Bionano Genomics (BNGO) stock price & financials

    View BNGO earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance70.0% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $6.07M
    $8.16M
    $6.46M
    $6.73M
    $7.37M
    +21.3%
    $7.95M
    -2.6%
    $6.69M
    +3.6%
    $8.17M
    +21.4%
    Strengthening
    Operating Profit
    -$43.90M
    -$11.94M
    -$8.46M
    -$7.80M
    -$8.54M
    +80.6%
    -$8.54M
    +28.5%
    -$7.90M
    +6.7%
    -$7.22M
    +7.5%
    Strengthening
    Net Profit
    -$44.25M
    -$20.13M
    -$3.10M
    -$6.86M
    -$8.50M
    +80.8%
    -$7.93M
    +60.6%
    -$8.30M
    -167.7%
    -$7.42M
    -8.3%
    Weakening
    EPS
    $-30.92
    $-1.15
    $-1.99
    $-1.59
    +94.9%
    $-0.76
    +33.9%
    $-0.64
    +67.8%
    Strengthening
    Other Income
    -$321.0K
    -$8.18M
    $5.37M
    $953.0K
    $49.0K
    $639.0K
    -$396.0K
    -107.4%
    -$198.0K
    -120.8%
    Weakening
    Interest
    Depreciation
    Profit before Tax
    -$44.22M
    -$20.12M
    -$3.10M
    -$6.85M
    -$8.49M
    +80.8%
    -$7.90M
    +60.8%
    -$8.29M
    -167.9%
    -$7.42M
    -8.3%
    Weakening
    MarginsOPM
    -722.9%
    -146.3%
    -131.1%
    -115.8%
    -115.9%
    +84.0%
    -107.4%
    +26.6%
    -118.1%
    +9.9%
    -88.3%
    +23.7%
    Strengthening
    Tax
    -0.1%
    0.0%
    -0.2%
    -0.1%
    -0.2%
    -220.0%
    -0.5%
    -0.1%
    +47.8%
    -0.1%
    +40.0%
    Strengthening
    ReturnsROIC
    6.0%
    2.7%
    0.4%
    0.9%
    1.2%
    -80.8%
    1.1%
    -60.6%
    1.1%
    +167.7%
    1.0%
    +8.3%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$16.52M$17.31M$38.45M$24.57M$5.09M$17.95M$9.17M$2.99M$3.73M
    Short-Term Investments
    Total Current Assets$23.03M$28.26M$46.79M$272.41M$157.30M$140.12M$39.49M$45.39M$24.88M
    Net PP&E$1.78M$1.95M$4.91M$17.01M$25.25M$28.98M$21.02M$18.06M$15.95M
    Goodwill$0$7.17M$56.16M$77.29M$0
    Intangibles$0$1.48M$26.84M$41.14M$33.97M$9.71M$4.34M$1.67M
    Total Assets$24.80M$30.21M$60.45M$377.10M$307.50M$214.40M$76.67M$73.58M$47.59M
    LiabilitiesTotal Current Liabilities$4.52M$26.37M$8.95M$21.84M$35.88M$100.03M$37.34M$22.94M$10.04M
    Short-Term Debt$0$20.08M$0
    Long-Term Debt$9.03M$0$16.32M$0
    Long-Term Leases$0$5.29M$5.50M$3.59M$145.0K$2.49M$2.38M
    Total Liabilities$14.67M$26.59M$25.37M$39.98M$58.10M$118.25M$41.30M$29.16M$15.98M
    EquityCommon Stock & APIC$1.0K$3.4K$19.0K$29.0K$3.0K$0$0$1.0K$1.0K
    Retained Earnings-$72.76M-$102.58M-$143.68M-$216.12M-$348.71M-$581.21M-$693.23M-$719.62M-$735.35M
    Total Equity$10.14M$3.61M$35.08M$337.12M$249.40M$96.16M$35.38M$44.42M$31.61M
    HighlightsNet Cash / (Debt)$7.49M-$2.77M$22.12M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$19.94M-$29.53M-$38.31M-$71.93M-$124.82M-$125.18M-$68.92M-$16.34M-$20.48M
    Cash from Investing-$331.7K-$61.1K-$2.45M-$278.06M$82.77M$24.16M$73.84M-$12.75M$18.48M
    Cash from Financing$35.78M$30.38M$61.90M$336.11M$23.01M$113.81M-$13.69M$24.04M$2.64M
    SummaryCapital Expenditure-$331.7K-$61.1K$0
    Free Cash Flow-$20.28M-$29.59M-$38.31M
    FCF Margin-169.0%-292.1%-450.6%

    Ratios